Home/Filings/4/0001127602-24-014504
4//SEC Filing

Bradway Robert A 4

Accession 0001127602-24-014504

CIK 0000318154other

Filed

May 6, 8:00 PM ET

Accepted

May 7, 8:30 PM ET

Size

5.5 KB

Accession

0001127602-24-014504

Insider Transaction Report

Form 4
Period: 2024-05-05
Bradway Robert A
Executive V.P. and CFO
Transactions
  • Tax Payment

    Common Stock

    2024-05-05$311.29/sh2,220$691,064657,281 total
Footnotes (2)
  • [F1]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 4,516 RSUs which will vest on 4/30/2025; 9,234 RSUs which will vest in installments of 4,548 on 5/2/2025, and 4,686 on 5/2/2026; and 13,486 RSUs which will vest in two installments of 4,450 each on 5/2/2025 and 5/2/2026, and one installment of 4,586 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F2]These shares include 1,555 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001396482

Filing Metadata

Form type
4
Filed
May 6, 8:00 PM ET
Accepted
May 7, 8:30 PM ET
Size
5.5 KB